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S U M M A R Y
Penicillium marneffei is a thermally dimorphic pathogenic fungus that causes systemic infection similar
to disseminated cryptococcosis. P. marneffei is endemic in Southeast Asia, usually infecting HIV-infected
individuals; infection of HIV-negative individuals is extremely rare. Here, we describe a disseminated P.
marneffei infection within an osteolytic lesion in an HIV-negative patient. A 40-year-old Chinese woman
presented with intermittent fever, generalized lymphadenopathy, and a skin rash. Following a sternum
biopsy, the patient was diagnosed with P. marneffei infection. An emission computed tomography bone
scan revealed the presence of increased radioactivity in the left clavicle and sternum, indicative of an
osteolytic lesion. In addition to reporting this very rare case, we also present a brief review of the
literature, highlighting the differences in clinical manifestations between HIV-positive and HIV-negative
patients infected with P. marneffei as it applies to our case.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
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Penicillium marneffei is one of a small number of species of
dimorphic fungi that grows as a mycelium at 25 8C and as a yeast at
37 8C in Southeast Asia. The ﬁrst human infection occurred in 1973,
as reported by Disalvo et al.1 While Penicillium strains are not
usually associated with infection, P. marneffei infection can be fatal
in immunocompromised individuals, including those who are HIV-
positive. The route of transmission is not completely clear, but it is
hypothesized to enter the host by inhalation from a contaminated
reservoir and disseminate to other organs by hematogenous
spread. Further, its dimorphic nature is thought to contribute to its
pathogenicity, with conversion to the yeast phase within the host
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On May 9, 2012, a 40-year-old Chinese woman was admitted
complaining of intermittent fever, generalized lymphadenopathy,
and a skin rash for 7 months. The patient was from Congzuo County
in the Guangxi region of southern China. She had been treated
previously for bacteremia, tuberculosis, and Mycobacterium
tuberculosis, but the fever and lymphadenopathy had persisted
and there was no clinical improvement. In March 2012, a right
cervical lymph node biopsy revealed chronic pyogenic inﬂamma-
tion, but staining for fungi and acid-fast bacilli was negative. She
had lost 10 kg, and 10 months prior to hospital admission she was
diagnosed with subacute thyroiditis at a local hospital and was
administered dexamethasone orally (5 mg/dl) for nearly 2 months.
She appeared pale and chronically ill on the day of admission to
The First Afﬁliated Hospital of Guangxi Medical University, and a
physical examination revealed a high-grade fever. Multiple
instances of erythema were present on the face, arms, and legs.
Lymphadenopathy was present over the bilateral neck, bilateral
axillary, and bilateral inguinal lymph nodes. A full blood panel wasciety for Infectious Diseases. Open access under CC BY-NC-ND license.
Figure 1. An ECT bone scan showing increased radioactive concentration in the sternum and left clavicle. (A) The initial scan showed high levels of radioactivity, May 31, 2012.
(B) August 9, 2012; (C) October 12, 2012; (D) November 20, 2012: the abnormal radioactivity decreased gradually over time.
G.- Liu et al. / International Journal of Infectious Diseases 23 (2014) 1–32obtained and the laboratory results are shown in Table S1 in the
Supplementary Material. The patient was HIV-negative and
negative for other blood-borne pathogens, including hepatitis B
virus and Syphilis pathogens. Further, she had normal T lymphocyte
cell counts (Supplementary Material, Table S1). Computed
tomography scans revealed bilateral spotted ﬂake shadows on
both lungs (Supplementary Material, Figure S1). At that time, the
patient was diagnosed with non-tuberculous mycobacteria, butwas unresponsive to isoniazid, rifampin, moxiﬂoxacin, and
cefoxitin therapy. After 3 weeks, the patient complained of aches
in her left clavicle and sternum. A follow-up lung CT showed the
left clavicle and sternum to have deteriorated signiﬁcantly and
surrounding tissues were swollen (Supplementary Material,
Figure S2). An emission CT (ECT) bone scan showed abnormal
increased radioactive concentration in the sternum and left
clavicle (Figure 1A). A subsequent sternum biopsy specimen
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mentary Material, Figure S3).
The patient was treated with, and responded well to,
amphotericin B at 50 mg/dl via intravenous administration
starting on June 4, 2012. Her fever returned to normal and her
chest pain also disappeared gradually 5 days after treatment. She
continued to receive antifungal treatment. A series of bone ECT and
lung CT scans showed the radioactivity concentration to taper off
gradually in her left clavicle and sternum (Fig. 1, B–D) and all of her
laboratory results returned to normal.
3. Discussion
P. marneffei within an osteolytic lesion in an HIV-negative
person is a rarely reported diagnosis. This patient’s corticosteroid
treatment for subacute thyroiditis, which affected the patient’s
immune function, possibly increased her chance of infection. The
symptoms that lead to the diagnosis of P. marneffei infection are
often non-speciﬁc and it tends to be regularly misdiagnosed.
Cases of P. marneffei in non-HIV-infected patients are rare and
other reports have shown that there are different clinical
manifestations between HIV-positive and HIV-negative patients,2,3
including: (1) a delay in penicilliosis diagnosis in HIV-negative
patients due to common misdiagnosis, leading more often to
chronic progression of the disease when compared to HIV-positive
patients;2,3 (2) signiﬁcantly higher levels of total white cell counts
in HIV-negative patients vs. HIV-positive patients;3 (3) higher
incidences of fungemia in HIV-positive patients, whereas a tissue
specimen is often necessary for diagnosis in HIV-negative hosts;2
(4) higher serum antigen titers in HIV-positive patients, while
serum antibody levels are found to be higher in HIV-negative
patients,2 as determined by a P. marneffei-speciﬁc mannoprotein
Mp1p ELISA;2 (5) different histopathological reactions, including
granulomatous and suppurative reactions, are seen in patients
with ‘normal’ immune systems, while anergic and necrotizing
reactions are seen in patients with compromised immune
systems.3 All of these differences are more than likely associated
with the different immune status and neutrophil functions of HIV-
negative and HIV-positive patients.
P. marneffei infection in bone is rare, which indicates that
systemic disturbance can be severe. Of note, previous reports of P.
marneffei infection presenting in osteolytic lesions, speciﬁcally in
ﬂat bones, long bones of the extremities, and the small bones of the
hands and feet, have mostly involved HIV-negative patients;3,4 the
reasons for this phenomenon are still not fully understood. Theprevailing hypothesis is that osteolytic lesions are typically a site of
neutrophil accumulation and release of proteolytic enzymes.
Considering HIV-positive patients have decreased neutrophil
function, it is no surprise that P. marneffei infection is rarely seen
in these instances.
Considering the presence of disseminated P. marneffei infection
and osteolytic lesions, we thought that the patient needed stronger
antifungal treatment for a longer period than individuals with non-
osteolytic P. marneffei infections. The patient was ﬁrst treated with
amphotericin B (50 mg) for nearly 2 months with a good treatment
response, showing that her general physical condition had
improved greatly, and the bone ache disappeared completely.
Follow-up ECT bone scans showed the radioactive concentration to
decrease gradually during the 3-month course of treatment.
P. marneffei-infected osteolytic lesions in non-HIV-infected
patients is rare and easily misdiagnosed. We have described in
detail the case of an HIV-negative woman with disseminated P.
marneffei infection in an osteolytic lesion and compared the
differences in clinical manifestations between HIV-positive and
HIV-negative patients.
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Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.ijid.2013.12.019.
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